COMPARATIVE BIOAVAILABILITY OF NOVEL CYCLOSPORINE FORMULATIONS VERSUS REFERENCE ORAL CYCLOSPORINE IN HEALTHY SUBJECTS UNDER FASTING CONDITIONS

William Sandborn  1     Jesse Hall  2     Peter Gardzinski  2     Mónica Rosa  3     Bernard McDonald  3     Walter Reinisch  4    
1 University of California San Diego, La Jolla, United States
2 Sublimity Therapeutics Inc., Solana Beach, United States
3 Sublimity Therapeutics Holdco Limited, Dublin, Ireland
4 Medical University of Vienna, Vienna, Austria

Session
IBD (Posters)

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing